Overview
Takehiko Doi practices in Hiroshima, Japan. Doi is rated as an Experienced expert by MediFind in the treatment of Pyruvate Kinase Deficiency. Their top areas of expertise are Idiopathic Pulmonary Hemosiderosis, Hemosiderosis, Virus Associated Hemophagocytic Syndrome, Reticulohistiocytoma, and Splenectomy.
Their clinical research consists of co-authoring 35 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Pyruvate Kinase Deficiency.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Idiopathic Pulmonary Hemosiderosis
- Advanced
- Hemophagocytic Lymphohistiocytosis
- HemosiderosisDoi isAdvanced. Learn about Hemosiderosis.
- HistiocytosisDoi isAdvanced. Learn about Histiocytosis.
- Langerhans Cell Histiocytosis
- Non-Langerhans-Cell Histiocytosis
- Reticulohistiocytoma
- Experienced
- Acute Interstitial Pneumonia
- ADULT SyndromeDoi isExperienced. Learn about ADULT Syndrome.
- CHARGE SyndromeDoi isExperienced. Learn about CHARGE Syndrome.
- Childhood Hypophosphatasia (HPP)
- Congenital AthymiaDoi isExperienced. Learn about Congenital Athymia.
- Hypophosphatasia (HPP)Doi isExperienced. Learn about Hypophosphatasia (HPP).